Diagnostic value of immunohistochemistry for the detection of the BRAFV600E mutation in primary lung adenocarcinoma Caucasian patients. (Q43853831)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

title

Diagnostic value of immunohistochemistry for the detection of the BRAFV600E mutation in primary lung adenocarcinoma Caucasian patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Marius Ilié

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Elodie Long

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Charles Marquette

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Andreas von Deimling

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

V Hofman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

B Dadone

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

J M Vignaud

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

H Begueret

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

J P Merlio

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

D Capper

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

J F Emile

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

P Hofman

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

publication date

6 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131393%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

742-748

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23131393%20AND%20SRC:MED&resulttype=core&format=json

Molecular pathology of lung cancer: key to personalized medicine

17 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

Role of molecular studies in the diagnosis of lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

Use of mutation specific antibodies to detect EGFR status in small biopsy and cytology specimens of lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

Immunohistochemical detection of EGFR mutation using mutation-specific antibodies in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

CEP-32496: a novel orally active BRAF(V600E) inhibitor with selective cellular and in vivo antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

Novel therapeutic targets in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

Sorafenib inhibits non-small cell lung cancer cell growth by targeting B-RAF in KRAS wild-type cells and C-RAF in KRAS mutant cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

Synergistic antitumor efficacy of sequentially combined paclitaxel with sorafenib in vitro and in vivo NSCLC models harboring KRAS or BRAF mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

Clinical characteristics of patients with lung adenocarcinomas harboring BRAF mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

Immunohistochemical detection of the BRAF V600E-mutated protein in papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

Sensitive sequencing method for KRAS mutation detection by Pyrosequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

High frequency of mutations of the PIK3CA gene in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

Uncommon V599E BRAF mutations in Japanese patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

Genetic predictors of MEK dependence in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

Micropapillary lung adenocarcinoma: EGFR, K-ras, and BRAF mutational profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

The histopathology of BRAF-V600E-mutated lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

Pitfalls in lung cancer molecular pathology: how to limit them in routine practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534

Usefulness of tissue microarrays for assessment of protein expression, gene copy number and mutational status of EGFR in lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS534